HomeStock ScreenerVasa DenticityQuarterly Results

Vasa Denticity Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹5 Cr
QSept 2025
Quarterly Results

In Sept 2025, Vasa Denticity (DENTALKART) reported revenue ₹74 Cr and net profit ₹5 Cr — revenue +23.3% YoY. Compare with DENTALKART fair price to assess whether the stock is under or overvalued.

DENTALKART Quarterly Results — Revenue, Profit & EPS Highlights

Vasa Denticity latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore DENTALKART price movement history to track price trends across different timeframes.

  • Revenue of ₹74 Cr in Sept 2025 (+1.4% vs Mar 2025, +23.3% vs Sept 2024)
  • Net Profit of ₹5 Cr in Sept 2025 (+25.0% vs Mar 2025, +0.0% vs Sept 2024)
  • EBITDA of ₹7 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 8.0% in Sept 2025 (-1.0pp vs Mar 2025)
  • Earnings Per Share of ₹2.83 in Sept 2025 (+11.4% vs Mar 2025)

Vasa Denticity Quarterly Results — Revenue, EBITDA, Net Profit & EPS

DENTALKART quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 74 73 62 73 60 1.4% 23.3%
Net Profit (₹ Cr) 5 4 3 1 5 - -
EBITDA (₹ Cr) 7 7 4 3 7 - -
EPS (₹) 2.83 2.54 1.65 0.79 3.35 - -
Operating Margin (%) 8.0% 9.0% 5.0% 2.0% 11.0% - -

DENTALKART Share Price Trend — 1-Year Movement Across Quarterly Results

Vasa Denticity 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit DENTALKART stock price BSE.

Profitability Ratios

Profit Margin 6.8%
EBITDA Margin 9.5%
Operating Margin 8.0%
ROE (Annual) 14.9%

Balance Sheet Highlights

Total Assets ₹151 Cr
Total Equity ₹134 Cr
Current Assets ₹126 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹-4 Cr
Investing Cash Flow ₹-43 Cr
Financing Cash Flow ₹47 Cr
Net Cash Flow ₹1 Cr

DENTALKART vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Vasa Denticity latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹437,014.87 Cr 1847.9 14,875 3,125 +10.8% - 21.0% 142.1
Divis Laboratories
Sept 2025
₹175,726.93 Cr 6710.5 2,860 689 +7.1% - 24.1% 258.4
Torrent Pharmaceuti…
Sept 2025
₹147,504.68 Cr 4380.8 3,219 591 +11.3% - 18.4% 249.8
Lupin
Sept 2025
₹111,651.09 Cr 2379.5 6,921 1,485 +23.2% - 21.5% 73.5
Cipla
Sept 2025
₹110,213.60 Cr 1347.0 7,716 1,353 +12.0% - 17.5% 80.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores